上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。
RET-IN-4
RET-IN-4 是一种有效、选择性和具有口服活性的 RET 抑制剂，对 RET (WT)，RET (V804M) 和 RET (M918T) 的 IC50 分别为 1.29 nM，1.97 nM 和 0.99 nM。RET-IN-4 对 JAK2 (IC50 为 4.4 nM) 和 FLT3 (IC50 为 30.8 nM) 表现出更好的激酶选择性。RET-IN-4 具有抗癌作用。
RET-IN-4 Chemical Structure
CAS No. : 2436473-55-9
| 规格 | 是否有货 | ||
|---|---|---|---|
| 100 mg | 询价 | ||
| 250 mg | 询价 | ||
| 500 mg | 询价 |
* Please select Quantity before adding items.
| 生物活性 |
RET-IN-4 is a potent, selective and orally active RET inhibitor with IC50s of 1.29 nM, 1.97 nM, and 0.99 nM for RET (WT), RET (V804M), and RET (M918T), respectively. RET-IN-4 exhibits better kinases selectivity against JAK2 (IC50 of 4.4 nM) and FLT3 (IC50 of 30.8 nM). RET-IN-4 has anticancer effects[1]. |
IC50 & Target |
IC50: 1.29 nM (RET (WT)), 1.97 nM (RET (V804M)), and 0.99 nM (RET (M918T))[1] |
||||||
|---|---|---|---|---|---|---|---|---|---|
| 体外研究 (In Vitro) |
The proliferation of Ba/F3 cells transformed with NSCLC related KIF5B-RET fusion is effectively suppressed by RET-IN-4 (compound 9) (IC50 of 19 nM). RET-IN-4 displays less ‘off-target’ effects than BLU-667[1]. Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only. |
||||||||
| 体内研究 (In Vivo) |
RET-IN-4 (compound 9; p.o.; 10-20 mg/kg; p.o.; daily; for 10 days) treatment represses tumor growth driven by KIF5B-RET-Ba/F3 cells in a dose-dependent manner[1]. Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.
|
||||||||
| 分子量 |
546.60 |
||||||||
| Formula |
C27H31FN10O2 |
||||||||
| CAS 号 |
2436473-55-9 |
||||||||
| 运输条件 |
Room temperature in continental US; may vary elsewhere. |
||||||||
| 储存方式 |
Please store the product under the recommended conditions in the Certificate of Analysis. |
||||||||
| 参考文献 |
|
所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务